Brief: Appili Therapeutics Announces That FDA Accepts The ATI-1501 NDA
08/02/2023 12:19
Feb 8 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS ANNOUNCES THAT FDA ACCEPTS THE
ATI-1501 NDA
* APPILI THERAPEUTICS INC - PDUFA ACTION DATE OF SEPTEMBER
23,
2023
* APPILI THERAPEUTICS INC - APPILI IS WORKING WITH SAPTALIS
ON
SUPPORTING REVIEW PROCESS AND RESPONDING TO QUESTIONS POSED BY
FDA
Source text for Eikon: ID:nBw81k9QNa
Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez